BNP Paribas Upgrades Relx (RELX) to Outperform

Share on StockTwits

Relx (NYSE:RELX) was upgraded by BNP Paribas from an “underperform” rating to an “outperform” rating in a report released on Thursday, MarketBeat.com reports.

Separately, Barclays raised shares of Relx from an “equal weight” rating to an “overweight” rating in a research note on Monday, September 24th. One research analyst has rated the stock with a sell rating, one has issued a hold rating and four have given a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and an average target price of $23.00.

NYSE:RELX opened at $20.53 on Thursday. The company has a current ratio of 0.41, a quick ratio of 0.37 and a debt-to-equity ratio of 2.39. The stock has a market capitalization of $21.54 billion, a PE ratio of 19.93 and a beta of 0.57. Relx has a twelve month low of $19.23 and a twelve month high of $23.81.

Several large investors have recently bought and sold shares of RELX. Glenmede Trust Co. NA purchased a new position in shares of Relx in the third quarter worth about $149,000. Engineers Gate Manager LP purchased a new position in Relx during the third quarter worth about $203,000. Mission Wealth Management LP purchased a new position in Relx during the third quarter worth about $206,000. Capital Fund Management S.A. purchased a new position in Relx during the second quarter worth about $211,000. Finally, River Road Asset Management LLC purchased a new position in Relx during the third quarter worth about $224,000. 4.04% of the stock is currently owned by hedge funds and other institutional investors.

About Relx

RELX PLC provides information and analytics for professional and business customers in the United States and internationally. It operates through four segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment provides information and analytics to institutions and professionals.

See Also: Momentum Indicator: Relative Strength Index

Analyst Recommendations for Relx (NYSE:RELX)

Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.